Viewing Study NCT04856293

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:16 AM
Ignite Modification Date: 2026-05-19 @ 4:07 AM
Study NCT ID: NCT04856293
Status: COMPLETED
Last Update Posted: 2022-01-20
First Post: 2021-04-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Bioequivalence Study for Crizotinib Encapsulated Microsphere Formulation (eMS)
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Participants View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Crizotinib View
None Encapsulated Microsphere Formulation View
None Healthy adult participants View